Last reviewed · How we verify
Whole Body PET Baseline with 11C Rolipram
Whole Body PET Baseline with 11C Rolipram is a Small molecule drug developed by National Institute of Mental Health (NIMH). It is currently in Phase 1 development.
At a glance
| Generic name | Whole Body PET Baseline with 11C Rolipram |
|---|---|
| Sponsor | National Institute of Mental Health (NIMH) |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Pain in extremity
- Headache
- Panic attack
Key clinical trials
- PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Whole Body PET Baseline with 11C Rolipram CI brief — competitive landscape report
- Whole Body PET Baseline with 11C Rolipram updates RSS · CI watch RSS
- National Institute of Mental Health (NIMH) portfolio CI
Frequently asked questions about Whole Body PET Baseline with 11C Rolipram
What is Whole Body PET Baseline with 11C Rolipram?
Whole Body PET Baseline with 11C Rolipram is a Small molecule drug developed by National Institute of Mental Health (NIMH).
Who makes Whole Body PET Baseline with 11C Rolipram?
Whole Body PET Baseline with 11C Rolipram is developed by National Institute of Mental Health (NIMH) (see full National Institute of Mental Health (NIMH) pipeline at /company/national-institute-of-mental-health-nimh).
What development phase is Whole Body PET Baseline with 11C Rolipram in?
Whole Body PET Baseline with 11C Rolipram is in Phase 1.
What are the side effects of Whole Body PET Baseline with 11C Rolipram?
Common side effects of Whole Body PET Baseline with 11C Rolipram include Pain in extremity, Headache, Panic attack.